1995
DOI: 10.1097/00000421-199506000-00004
|View full text |Cite
|
Sign up to set email alerts
|

Cutaneous Neuroendocrine (Merkel Cell) Carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

2
54
1
1

Year Published

1999
1999
2014
2014

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 85 publications
(58 citation statements)
references
References 0 publications
2
54
1
1
Order By: Relevance
“…2,10,12,13 In addition, some have recommended a prophylactic lymphadenectomy due to the propensity for early occult spread to regional nodes. 14,15 More recently, sentinel lymph-node mapping has been used in MCC to detect the presence of regional nodal metastases. This technique allows one to perform selective lymph-node dissection.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…2,10,12,13 In addition, some have recommended a prophylactic lymphadenectomy due to the propensity for early occult spread to regional nodes. 14,15 More recently, sentinel lymph-node mapping has been used in MCC to detect the presence of regional nodal metastases. This technique allows one to perform selective lymph-node dissection.…”
Section: Discussionmentioning
confidence: 99%
“…14,15 These authors demonstrate improved locoregional control but no impact on survival. No comment is made about complications of the lymphnode dissection (edema, infection, and pain), so it is not clear at what cost this local benefit was obtained.…”
mentioning
confidence: 96%
“…[5][6][7] In 1 study of 35 patients with Merkel cell carcinoma who presented with Stage I and Stage II disease, there was an overall recurrence rate of 50% . 6 Regional lymph node recurrence comprised 47% of the total failure rate and the median time to this recurrence was 5 months. In addition, this study described lymph node recurrence even within previously dissected lymph node basins.…”
Section: Discussionmentioning
confidence: 99%
“…Historic data typically derived from small case series have reported dismal 5-year survival rates ranging from 29% to 64%. 7,9,10,19,[21][22][23] However, studies involving larger number of patients have suggested up to 74% survival rates at 5 years. 15,24,25 The most important prognostic determinant is tumor stage, 3,9,10,[24][25][26] which is most accurate if information of the pathologically confirmed status of the regional lymph nodes is included (pathologic stage).…”
mentioning
confidence: 99%